Urologic disorders include both urological malignancies and benign urologic diseases. In the context of clinical epidemiology, epidemiology of urologic diseases is concerned with prognosis and outcome of treatment among patients with urologic disorders. At Department of Clinical Epidemiology, we focus, in particular, on the long-term consequences of not only malignant but also benign urinary tract diseases.
Our research in urologic malignancies focuses on risk factors and prognostic factors for prostate cancer, kidney cancer, and bladder cancer, including the role of comorbidities, and the progression from carcinoma in-situ lesions to fulminant cancer. A specific focus is over-diagnosis and over-treatment of prostate cancer The uro-oncologic research at DCE is closelyinterwoven with our cancer epidemiology research.
Benign urological lower tract diseases are common and affect all age groups. Our research examines long-term consequences of benign urinary tract disorders, such as benign prostatic hyperplasia, urinary tract infections, and overactive bladder. This research aims to strengthen the level of scientific evidence within clinical urology, thus providing knowledge needed to prioritize resources and guide clinical decision-making.
